Kaposi's sarcoma responding to topical imiquimod 5% cream: a case report
Tóm tắt
Kaposi's sarcoma, a virus-associated neoplasm, can be treated with systemic therapy such interferon or chemotherapy, although a local alternative is possible in localized disease. Topical imiquimod is a ligand of the toll-like receptors 7 and 8 on dendritic cells, increasing immune responses and showing antiviral and antitumoral activities. We report a spectacular response to imiquimod 5% cream in a patient with classic Kaposi's sarcoma of the leg.
Tài liệu tham khảo
Morand JJ, Lightburn E, Simon F, Patte JH: Update on Kaposi's sarcoma. Med Trop (Mars). 2007, 67: 123-130.
Di lorenzo G: Update on classic Kaposi sarcoma therapy: New look at an old disease. Crit Rev Oncol Hematol. 2008, 68: 242-249. 10.1016/j.critrevonc.2008.06.007.
Sauder DN: Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermato. 2000, 43: S6-S11. 10.1067/mjd.2000.107808.
Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM: Treatment of genital warts with an immune response modifier (imiquimod). J Am Acad Dermatol. 1998, 38: 230-239. 10.1016/S0190-9622(98)70243-9.
Hadley G, Derry S, Moore RA: Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol. 2006, 126: 1251-1255. 10.1038/sj.jid.5700264.
Rosen T: Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream. Int J Dermatol. 2006, 45: 854-856. 10.1111/j.1365-4632.2006.02829.x.
Goiriz R, Rios-Buceta L, Gonzales De Arriba A, Aragues M, Garcia diez A: Treatment of Classic Kaposi's Sarcoma with Topical Imiquimod. Dermatol Surg. 2009, 35: 147-149. 10.1111/j.1524-4725.2008.34397.x.
Celestin Schartz NE, Chevret S, Paz C, Kerob D, Verola O, Morel P, Lebbe C: Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: a phase I to II, open-label trial in 17 patients. J Am Acad Dermatol. 2008, 58: 585-591.